SCHEMBL25580327

SCHEMBL25580327

CC(C)OCCN(CCCCCCN1C(=O)C=CC1=O)CCOC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 8/20 0.41
FAAH O00519 5/20 0.41
HSP90AA1 P07900 1/20 0.41
TLR9 Q9NR96 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
XBP1 P17861 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR35 Q9HC97 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
PTGS1 P23219 7/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579903 0.91 MGLL (0.50) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25579919 0.90 MGLL (0.36) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25579935 0.90 MGLL (0.37) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25581871 0.84 MGLL (0.34) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25580331 0.80 MGLL (0.43) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL19466241 0.79 MGLL (0.42) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25580356 0.79 MGLL (0.42) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL20806108 0.77 MGLL (0.61) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25580394 0.77 MGLL (0.61) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL25580392 0.77 MGLL (0.61) MGLLFAAHHSP90AA1TLR9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof YAFEI SHANGHAI BIOLOG MEDICINE SCIENCE & TECHNOLOG (CN) 2023-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158141-A1 Conjugates of Biomolecule and Use Thereof CD47, FCGR2A, CD40 MGLL 2474/4885FAAH 2216/4885HSP90AA1 1851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.